Forward-Looking Statements

Statements about the potential of our nanoparticle platform, plans for IND-enabling studies, timelines, anticipated development milestones, and possible expansion into other brain diseases are forward-looking. Words like plan, expect, aim, designed to, potential, and intend generally signal them.

Drug development is uncertain. Preclinical results frequently do not translate to humans. Actual outcomes may differ materially because of risks including manufacturing and formulation challenges, results of toxicology and IND-enabling work, regulatory feedback and timing, availability of funding, intellectual property matters, competing approaches, and the general difficulty of treating glioblastoma.

Forward-looking statements speak only as of the date they are posted. We undertake no obligation to update them as new information becomes available.

Nothing on this site is an offer to sell or a solicitation to buy securities, and nothing here should be relied upon as the basis for an investment decision.